levofloxacin has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, TT; Ma, DY; Wang, L; Xie, XC | 1 |
| Baltch, AL; Bopp, LH; Carlyn, CJ; Carpenter-Knaggs, A; Hibbs, JR; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
2 other study(ies) available for levofloxacin and Carcinoma
| Article | Year |
|---|---|
[Acute suppurative otitis media caused by pasteurella multocida :a case report].
Topics: Anti-Bacterial Agents; Bites and Stings; Carcinoma; Humans; Levofloxacin; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Otitis Media, Suppurative; Pasteurella Infections; Pasteurella multocida | 2017 |
Levofloxacin kills Chlamydia pneumoniae and modulates interleukin 6 production by HEp-2 cells.
Topics: Anti-Infective Agents; Carcinoma; Chlamydia Infections; Chlamydophila pneumoniae; Hepatocytes; Humans; Interleukin-6; Levofloxacin; Liver Neoplasms; Ofloxacin; Tumor Cells, Cultured | 2003 |